IDEXX LABORATORIES INC /DE Insider Trading for August 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IDEXX LABORATORIES INC /DE for August 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 30,000 | 1,311,300 | 47,714 | |
| Aug 30 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 30,000 | 1,311,300 | 1,103,469 | 1.1 M to 1.1 M (+2.79 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 45.84 | 2,180 | 99,931 | 0 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 43.71 | 2,286 | 99,921 | 0 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 43.71 | 11,372 | 497,070 | 0 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 45.84 | 2,180 | 99,931 | 18,640 | 16.5 K to 18.6 K (+13.24 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 43.71 | 2,286 | 99,921 | 16,460 | 14.2 K to 16.5 K (+16.13 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 242.71 | 11,372 | 2,760,072 | 14,174 | 25.5 K to 14.2 K (-44.52 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 43.71 | 11,372 | 497,070 | 25,546 | 14.2 K to 25.5 K (+80.23 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | S | 141.60 | 2,219 | 314,210 | 8,167 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 9,400 | 637,790 | 12,627 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 245.06 | 3,264 | 799,887 | 7,634 | 10.9 K to 7.6 K (-29.95 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 244.15 | 2,806 | 685,089 | 10,898 | 13.7 K to 10.9 K (-20.48 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 243.36 | 5,549 | 1,350,399 | 13,704 | 19.3 K to 13.7 K (-28.82 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 141.60 | 2,219 | 314,210 | 19,253 | 17 K to 19.3 K (+13.03 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 9,400 | 637,790 | 17,034 | 7.6 K to 17 K (+123.13 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 67.85 | 1,500 | 101,775 | 9,249 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 79.54 | 2,226 | 177,056 | 136 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 62.00 | 2,112 | 130,944 | 0 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 243.75 | 74 | 18,038 | 3,333 | 3.4 K to 3.3 K (-2.17 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 243.78 | 5,838 | 1,423,174 | 3,407 | 9.2 K to 3.4 K (-63.15 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 67.85 | 1,500 | 101,775 | 9,245 | 7.7 K to 9.2 K (+19.37 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 79.54 | 2,226 | 177,056 | 7,745 | 5.5 K to 7.7 K (+40.33 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 62.00 | 2,112 | 130,944 | 5,519 | 3.4 K to 5.5 K (+61.99 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 10,000 | 437,100 | 77,714 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 20,000 | 874,200 | 87,714 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 10,000 | 437,100 | 107,714 | |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 247.33 | 7,000 | 1,731,290 | 1,073,469 | 1.1 M to 1.1 M (-0.65 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 10,000 | 437,100 | 1,080,469 | 1.1 M to 1.1 M (+0.93 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 245.89 | 12,300 | 3,024,496 | 1,070,469 | 1.1 M to 1.1 M (-1.14 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 245.12 | 3,700 | 906,941 | 1,082,769 | 1.1 M to 1.1 M (-0.34 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 20,000 | 874,200 | 1,086,469 | 1.1 M to 1.1 M (+1.88 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 243.20 | 7,000 | 1,702,418 | 1,066,469 | 1.1 M to 1.1 M (-0.65 %) |
| Aug 23 2018 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 10,000 | 437,100 | 1,073,469 | 1.1 M to 1.1 M (+0.94 %) |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 2 | 136 | 1,475 | |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 1,783 | 141,820 | 2,512 | |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 2 | 136 | 7,634 | 7.6 K to 7.6 K (+0.03 %) |
| Aug 10 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 1,783 | 141,820 | 7,632 | 5.8 K to 7.6 K (+30.48 %) |
| Aug 09 2018 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
| Aug 09 2018 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 12,000 | 0 | 3,416 | 15.4 K to 3.4 K (-77.84 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 8,598 | 683,885 | 5,732 | |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 242.87 | 3,010 | 731,037 | 5,849 | 8.9 K to 5.8 K (-33.98 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 242.10 | 5,588 | 1,352,834 | 8,859 | 14.4 K to 8.9 K (-38.68 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 8,598 | 683,885 | 14,447 | 5.8 K to 14.4 K (+147.00 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 64.69 | 2,986 | 193,164 | 2,988 | |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 46.91 | 2,952 | 138,478 | 0 | |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 240.64 | 1,750 | 421,123 | 8,848 | 10.6 K to 8.8 K (-16.51 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 64.69 | 2,986 | 193,164 | 10,598 | 7.6 K to 10.6 K (+39.23 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 240.64 | 1,515 | 364,572 | 7,612 | 9.1 K to 7.6 K (-16.60 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 46.91 | 2,952 | 138,478 | 9,127 | 6.2 K to 9.1 K (+47.81 %) |
| Aug 07 2018 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Buy | P | 242.12 | 415 | 100,480 | 1,415 | 1,000 to 1.4 K (+41.50 %) |
| Aug 01 2018 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 237.76 | 79 | 18,783 | 6,175 | 6.1 K to 6.2 K (+1.30 %) |
| Aug 01 2018 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Grant | A | 237.76 | 105 | 24,965 | 4,759 | 4.7 K to 4.8 K (+2.26 %) |
| Aug 01 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 237.76 | 25 | 5,944 | 2,684 | 2.7 K to 2.7 K (+0.94 %) |
| Aug 01 2018 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 237.76 | 79 | 18,783 | 389 | 310 to 389 (+25.48 %) |